Charting a course through the CEAs: diagnosis and management of medullary thyroid cancer

被引：1
|
作者：
Rowe, Christopher W. [1 ,2 ]
Bendinelli, Cino [2 ,3 ]
McGrath, Shaun [1 ]
机构：
[1] John Hunter Hosp, Dept Endocrinol, Newcastle, NSW, Australia
[2] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia
[3] John Hunter Hosp, Dept Surg, Newcastle, NSW, Australia
来源：
CLINICAL ENDOCRINOLOGY | 2016年 / 85卷 / 03期
关键词：
SERUM CALCITONIN; PROGNOSTIC-FACTORS; CARCINOMA; F-18-DOPA; F-18-FDG; FEATURES; PET/CT; IMPACT;
D O I：
10.1111/cen.13114
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Medullary thyroid cancer (MTC) is an uncommon thyroid cancer that requires a high index of suspicion to facilitate diagnosis of early-stage disease amenable to surgical cure. The challenges of diagnosis, as well as management in the setting of persistent disease, are explored in the context of a case presenting with the incidental finding of elevated carcinoembryonic antigen (CEA) and an F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET)-positive thyroid incidentaloma detected following treatment of colorectal cancer. Strategies to individualize prognosis, and emerging PET-based imaging modalities, particularly the potential role of F-18-DOPA-PET in staging, are reviewed.
引用
收藏
页码：340 / 343
页数：4
相关论文
共 50 条
  • [1] Clinical comments related to medullary thyroid cancer diagnosis and management
    Duntas L.H.
    Thyroid Research, 6 (Suppl 1)
  • [2] Management of medullary thyroid cancer
    Ball, D. W.
    MINERVA ENDOCRINOLOGICA, 2011, 36 (01) : 87 - 98
  • [3] Diagnosis and management of medullary thyroid carcinoma
    Massoll, N
    Mazzaferri, EL
    CLINICS IN LABORATORY MEDICINE, 2004, 24 (01) : 49 - +
  • [4] Management of Medullary Thyroid Cancer
    Viola, David
    Elisei, Rossella
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 285 - +
  • [5] Diagnosis and treatment of medullary thyroid cancer
    Modigliani, E
    Franc, B
    Niccoli-sire, P
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 14 (04) : 631 - 649
  • [6] Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer
    Zarkesh, Maryam
    Arab, Noman
    Tavangar, Seyed Mohmmad
    Nozhat, Zahra
    Fanaei, S. Melika
    Hedayati, Mehdi
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 229
  • [7] Medullary thyroid cancer diagnosis: An appraisal
    Trimboli, Pierpaolo
    Giovanella, Luca
    Crescenzi, Anna
    Romanelli, Francesco
    Valabrega, Stefano
    Spriano, Giuseppe
    Cremonini, Nadia
    Guglielmi, Rinaldo
    Papini, Enrico
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (08): : 1216 - 1223
  • [8] DIAGNOSIS OF MEDULLARY-THYROID CANCER
    SANDROCK, D
    MUNZ, DL
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1991, 116 (02) : 77 - 78
  • [9] Current diagnosis and management of medullary thyroid carcinoma
    Giuffrida, D
    Gharib, H
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 695 - 701
  • [10] MEDULLARY CARCINOMA OF THE THYROID - CURRENT DIAGNOSIS AND MANAGEMENT
    LAIRMORE, TC
    WELLS, SA
    SEMINARS IN SURGICAL ONCOLOGY, 1991, 7 (02): : 92 - 99
12345